Euryops algoensis
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Euryops algoensis |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Euryops Algoensis |
| Ipni Id | 207377-1 |
| Plant Name | Euryops Algoensis |
| Genus Tax Id | 109562 |
| Disease Name | Solid tumour/cancer, Colorectal cancer, Myeloproliferative neoplasm, Follicular lymphoma, Alzheimer disease, Stomach cancer, Breast cancer, Head and neck cancer, Acute diabete complication, Renal cell carcinoma, Schizophrenia, Glaucoma, Neuropathy, Lung cancer, Ovarian cancer, Coronary thrombosis, Acute myeloid leukaemia, Genetic prion disease, Chronic myelomonocytic leukaemia, Psoriasis, Kaposi sarcoma, Fungal infection, Bleeding disorder, Pancreatic cancer, Muscular dystrophy, Heart failure, Prostate cancer, Seborrhoeic dermatitis, Pituitary gland disorder, Multiple myeloma, Autonomic nervous system disorder, Pain, unspecified, Diffuse large B-cell lymphoma, Myelodysplastic syndrome, Retinopathy, Thrombocytosis, Dystrophic epidermolysis bullosa, Duodenal ulcer, Low bone mass disorder, Melanoma, Bacterial infection, Essential hypertension, Indeterminate colitis, Mature B-cell lymphoma, Rheumatoid arthritis, Atopic eczema, Ischaemic/haemorrhagic stroke, Type 2 diabetes mellitus, Angina pectoris, Choreiform disorder, Lupus erythematosus, Irritable bowel syndrome, Parkinsonism, Nutritional deficiency, Thrombosis, Motor neuron disease, Diagnostic imaging, Skin and skin-structure infection, Myocardial infarction, BCR-ABL1-negative chronic myeloid leukaemia, Multiple sclerosis, Ovarian dysfunction, Amyloidosis, Asthma, Cerebral ischaemic stroke, Thrombocytopenia, Bladder cancer, Insomnia, Colon cancer, Coagulation defect, Malignant haematopoietic neoplasm, Diabetes mellitus, type unspecified, Liver cancer, Desmoid tumour, Cardiovascular disease, Cataract, Acute/subacute hepatic failure, Mature T-cell lymphoma, Mature B-cell leukaemia, Parasitic infection, Brain cancer, Duchenne muscular dystrophy, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Lichen planus, Pulmonary hypertension, Intracranial injury, unspecified, Complete trisomy 21, Ductal carcinoma in situ of breast, Uterine fibroid, Hepatic fibrosis/cirrhosis, Endometriosis, Malignant neoplasms of colon, Prostate hyperplasia, Neoplasms, Idiopathic pulmonary fibrosis, Fragile X chromosome, Multiple system atrophy, Unspecified viral infection of unspecified site, Malignant neoplasms of bladder, unspecified, Becker muscular dystrophy, Malignant neoplasms of nasopharynx, Columnar metaplastic epithelium of the oesophagus, unspecified, Systemic lupus erythematosus, Adenocarcinoma of prostate, Leukaemia, Non-small cell lung cancer, Huntington disease, Osteoporosis, Anogenital warts, Relapsing-remitting multiple sclerosis, Carcinosarcoma of uterus, Crohn disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Inflammatory bowel diseases, unspecified, Osteoarthritis, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Other specified malignant neoplasms of kidney, except renal pelvis, Keratoconus, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Chronic rhinosinusitis, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Malignant neoplasms of thymus, Invasive carcinoma of breast, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Malignant neoplasms of adrenal gland |
| Species Name | Euryops algoensis |
| Genus Name | Euryops |
| Species Tax Id | 551044 |
| Disease Id | 2A00-2F9Z, 2B91, 2A20, 2A80, 8A20, 2B72, 2C60-2C6Y, 2D42, 5A2Y, 2C90, 6A20, 9C61, 8C0Z, 2C25, 2C73, BA43, 2A60, 8.00E+02, 2A40, EA90, 2B57, 1F29-1F2F, GA20-GA21, 2C10, 8C70, BD10-BD1Z, 2C82, EA81, 5A60-5A61, 2A83, 8D87, MG3Z, 2A81, 2A37, 9B71, 3B63, EC32, DA63, FB83, 2C30, 1A00-1C4Z, BA00, DD72, 2A85, FA20, EA80, 8B20, 5A11, BA40, 8A01, 4A40, DD91, 8A00, 5B50-5B71, DB61-GB90, 8B60, N.A., 1F28-1G0Z, BA41-BA43, 2A41, 8A40, 5A80, 5D00, CA23, 8B11, 3B64, 2C94, 7A00-7A0Z, 2B90, 3B10, 2B33, 5A14, 2C12, 2F7C, BA00-BE2Z, 9B10, DB91, 2A90, 2A82, 1D0Y-1G2Z, 2A00, 8C70.1, 1C62.Z, EA91, BB01, NA07.Z, LD40.0, 2E65.2, 2.00E+66, DB93, GA10, GA90, 2, CB03.4, LD55, 8D87.0, 1D9Z, 2C94.Z, 8C70.0, 2B6B, DA23.Z, 4A40.0, 2C82.0, 2A60-2B33, 8A01.10, FB83.1, 1A95, 8A40.0, 2C76.43, DD70, 2C73.4, XH3854, DD7Z, FA0Z, 2C15, 2C12.01, 1F54, 2B72.0, BC81.3, 2D60.0, 2C90.Y, 9A78.50, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, 2C12.02, 2C25.Y, GA10.B4, 2B70, 2C94.2, 1D82, CA0A, 2D10.Z, 2C25.0, 2C76.Z, 2C27, 2C61, 2A00.00, XH6153, 2C80.2, 2D11 |
| Family Name | Asteraceae |
| Family Tax Id | 4210 |
- 1. (1r,2r,20r,42r,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3r,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162996097)
- 2. (1r,2r,20r,42r,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3s,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163193936)
- 3. (1r,2r,20r,42s,46r)-15-[(1r,2s,20s,42s,46s)-7,8,9,12,13,14,20,25,26,27,30,31,32,35,36,37-Hexadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163192207)
- 4. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163191667)
- 5. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-46-[(2s,3r,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162818361)
- 6. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-46-[(2s,3s,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162818358)
- 7. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2r,3r,4r,5s)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162996101)
- 8. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3r,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163193937)
- 9. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3s,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163194913)
- 10. (1r,2r,20r,42s,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162924018)
- 11. (1r,2r,20s,42s,46s)-15-[(1r,2s,20s,42r,46s)-7,8,9,12,13,14,20,25,26,27,30,31,32,35,36,37-Hexadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2r,3r,4r,5s)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162818371)
- 12. (1r,2r,20s,42s,46s)-15-[(1r,2s,20s,42s,46s)-7,8,9,12,13,14,20,25,26,27,30,31,32,35,36,37-Hexadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163192017)
- 13. (1r,2r,20s,42s,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-46-Carboxylic Acid (PubChem CID: 163029476)
- 14. (1r,2r,4ar,5r,8ar)-4a-Methyl-8-Methylidene-2-Propan-2-Yl-1,2,3,4,5,6,7,8a-Octahydronaphthalene-1,5-Diol (PubChem CID: 11746695)
- 15. (1r,2s,19r,41s,45r)-7,8,9,12,13,14,24,25,26,30,31,34,35,36,45-Pentadecahydroxy-29-Methyl-3,18,20,40,42-Pentaoxanonacyclo[26.13.3.137,41.02,19.05,10.011,16.022,27.032,44.033,38]pentatetraconta-5,7,9,11,13,15,22,24,26,28,30,32(44),33(38),34,36-Pentadecaene-4,17,21,39,43-Pentone (PubChem CID: 162962894)
- 16. (1s,2r,20r,42s,46r)-7,8,9,12,13,14,26,27,30,31,32,35,36,37,46-Pentadecahydroxy-25-[[(1s,2r,20s,42s,46r)-7,8,9,12,13,25,26,27,30,31,32,35,36,37,46-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-14-Yl]oxy]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163192218)
- 17. (1s,2r,20s,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162934486)
- 18. (1s,2r,20s,42s,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163193900)
- 19. (1s,2s,19r,41r,45s)-7,8,9,12,13,14,24,25,26,30,31,34,35,36,45-Pentadecahydroxy-29-Methyl-3,18,20,40,42-Pentaoxanonacyclo[26.13.3.137,41.02,19.05,10.011,16.022,27.032,44.033,38]pentatetraconta-5,7,9,11,13,15,22,24,26,28,30,32(44),33(38),34,36-Pentadecaene-4,17,21,39,43-Pentone (PubChem CID: 162962893)
- 20. (2r,2'r,3s,3's,4s)-2,2'-Bis(3,4-Dihydroxyphenyl)-5,5',7,7'-Tetrahydroxy-[4,8'-Bichroman]-3,3'-Diyl Bis(3,4,5-Trihydroxybenzoate) (PubChem CID: 12795892)
- 21. (2s)-2-(3,8-Dimethylazulen-5-Yl)propanoic Acid (PubChem CID: 3083593)
- 22. (3s,4as,6as,6as,6br,8ar,12ar,14ar,14br)-4,4,4a,6a,6b,8a,11,11,14a-Nonamethyl-2,3,5,6,6a,7,8,9,10,12,12a,13,14,14b-Tetradecahydro-1h-Picen-3-Ol (PubChem CID: 162962747)
- 23. (3s,5r,8r,9r,10r,13s,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Ol (PubChem CID: 12309018)
- 24. (3s,5s,8r,9r,10r,13r,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Ol (PubChem CID: 162965657)
- 25. (4as,6as,6as,6br,8ar,12as,14as,14br)-4,4,6a,6b,8a,11,11,14a-Octamethyl-2,4a,5,6,6a,7,8,9,10,12,12a,13,14,14b-Tetradecahydro-1h-Picen-3-One (PubChem CID: 162992395)
- 26. (5r,8r,9s,10r,13r,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 12309262)
- 27. (5s,8r,9r,10r,13r,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 124303726)
- 28. (E)-Tetradec-5-En-1-Ol (PubChem CID: 6431325)
- 29. 1-Epi-Castalagin (PubChem CID: 12302512)
- 30. 3'',4''-Di-O-Acetyl-2'',6''-Di-O-P-Coumaroylastragalin (PubChem CID: 10328097)
- 31. 3-[(3s,3ar,5ar,6s,7r,9ar,9br)-3-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-6,9a,9b-Trimethyl-7-Prop-1-En-2-Yl-1,2,3,3a,4,5,5a,7,8,9-Decahydrocyclopenta[A]naphthalen-6-Yl]propanoic Acid (PubChem CID: 162903148)
- 32. 6-Tetradecen-1-Ol, (E) (PubChem CID: 6431327)
- 33. [(1r,2s,6s,7r,8s,9r,11s,13s,14s,15r,16s,17r)-2,11,15,16-Tetrahydroxy-9,13,17-Trimethyl-4,12-Dioxo-5,18-Dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadecan-7-Yl] (E)-2-Methylbut-2-Enoate (PubChem CID: 101046538)
- 34. [(2r,3r,4r)-4-[(2r,3s)-2-(3,4-Dihydroxyphenyl)-3,5,7-Trihydroxy-3,4-Dihydro-2h-Chromen-8-Yl]-5,7-Dihydroxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 13831071)
- 35. [(2r,3r,4s,5r,6s)-4,5-Diacetyloxy-6-[5,7-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxochromen-3-Yl]oxy-3-[(Z)-3-(4-Hydroxyphenyl)prop-2-Enoyl]oxyoxan-2-Yl]methyl (E)-3-(4-Hydroxyphenyl)prop-2-Enoate (PubChem CID: 10418008)
- 36. [(2r,3s)-2-(3,4-Dihydroxyphenyl)-8-[(2r,3r,4s)-8-[(2r,3r,4r)-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3,4-Dihydro-2h-Chromen-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163040999)
- 37. [(2r,3s)-2-(3,4-Dihydroxyphenyl)-8-[(2r,3r,4s)-8-[(2r,3r,4r)-2-(3,4-Dihydroxyphenyl)-8-[(2r,3r,4r)-8-[(2r,3s,4s)-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-3,4-Dihydro-2h-Chromen-4-Yl]-3,5,7-Trihydroxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-4-Yl]-3,5,7-Trihydroxy-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3,4-Dihydro-2h-Chromen-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162888081)
- 38. [(3r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-4,4a,6a,6b,8a,11,11,14a-Octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-Hexadecahydropicen-3-Yl] Acetate (PubChem CID: 13688749)
- 39. Acanthoside B (PubChem CID: 443024)
- 40. Beta-Sitosterol (PubChem CID: 222284)
- 41. Caryophyllene (PubChem CID: 5281515)
- 42. Chamazulene (PubChem CID: 10719)
- 43. Cianidanol (PubChem CID: 9064)
- 44. Cid 12302513 (PubChem CID: 12302513)
- 45. Epicatechin (PubChem CID: 72276)
- 46. Epicatechin 3-O-Gallate(4b->8)epigallocatechin-3-O-Gallate (PubChem CID: 11622083)
- 47. Epicatechin Gallate (PubChem CID: 107905)
- 48. Epicatechin-(4beta->8)-Epigallocatechin 3'-Gallate (PubChem CID: 11513300)
- 49. Epigallo Catechin Gallate (PubChem CID: 5276454)
- 50. Epigallocatechin (PubChem CID: 72277)
- 51. Epigallocatechin Gallate (PubChem CID: 65064)
- 52. Friedelin (PubChem CID: 91472)
- 53. Gallocatechin (PubChem CID: 65084)
- 54. Gentisic Acid (PubChem CID: 3469)
- 55. Glutinol (PubChem CID: 9932254)
- 56. Glutinone (PubChem CID: 10071029)
- 57. Kaempferol-3-O-(2',6'-Di-O-Trans-P-Coumaroyl)-Beta-D-Glucopyranoside (PubChem CID: 10439991)
- 58. P-Coumaric Acid (PubChem CID: 637542)
- 59. Phytic Acid (PubChem CID: 890)
- 60. Procyanidin B3 (PubChem CID: 146798)
- 61. Prodelphinidin B3 (PubChem CID: 13831068)
- 62. Quercitol (PubChem CID: 441437)
- 63. Scopoletin (PubChem CID: 5280460)
- 64. Taraxerol (PubChem CID: 92097)
- 65. Trachelosperogenin A1, >=95% (Lc/ms-Elsd) (PubChem CID: 21637743)
- 1. Alzheimer's Disease 1
- 2. Arthritis, Rheumatoid
- 3. Asthma
- 4. Cardiovascular Diseases
- 5. Cataract
- 6. Cholera
- 7. Crohn Disease
- 8. Diabetes Mellitus
- 9. Glaucoma
- 10. Inflammatory Bowel Diseases
- 11. Liver Neoplasms
- 12. Lupus Erythematosus, Systemic
- 13. Muscular Dystrophies
- 14. Myocardial Infarction
- 15. Osteoarthritis
- 16. Osteoporosis
- 17. Pre-Eclampsia
- 18. Psoriasis
- 19. Thrombocytopenia
- 20. Urinary Bladder Neoplasms
- 21. Uterine Cervical Neoplasms
Not listed in any formulations.